Johnson & Johnson (JNJ) | Aggregate Accruals
Earnings can be decomposed into cash and accrual components. The accrual component (aggregate accruals) has been found to have less persistence than the cash component, and therefore (1) earnings with higher accrual component are less persistent than earnings with smaller accrual component, all else equal; and (2) the cash component of earnings should receive a higher weighting evaluating company performance.
Balance-Sheet-Based Accruals Ratio
Johnson & Johnson, balance sheet computation of aggregate accruals
USD $ in millions
| Dec 30, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Operating Assets | ||||||
| Total assets | 121,347 | 113,644 | 102,908 | 94,682 | 84,912 | |
| Less: Cash and cash equivalents | 14,911 | 24,542 | 19,355 | 15,810 | 10,768 | |
| Less: Marketable securities | 6,178 | 7,719 | 8,303 | 3,615 | 2,041 | |
| Operating assets | 100,258 | 81,383 | 75,250 | 75,257 | 72,103 | |
| Operating Liabilities | ||||||
| Total liabilities | 56,521 | 56,564 | 46,329 | 44,094 | 42,401 | |
| Less: Loans and notes payable | 4,676 | 6,658 | 7,617 | 6,318 | 3,732 | |
| Less: Long-term debt | 11,489 | 12,969 | 9,156 | 8,223 | 8,120 | |
| Operating liabilities | 40,356 | 36,937 | 29,556 | 29,553 | 30,549 | |
| Net operating assets1 | 59,902 | 44,446 | 45,694 | 45,704 | 41,554 | |
| Balance-sheet-based aggregate accruals2 | 15,456 | (1,248) | (10) | 4,150 | ||
| Balance-Sheet-Based Accruals Ratio, Comparison to Industry | ||||||
| Johnson & Johnson3 | 29.62% | -2.77% | -0.02% | 9.51% | ||
| Industry, Health Care | 6.71% | 0.12% | 3.35% | 30.44% | ||
2012 Calculations
1 Net operating assets = Operating assets – Operating liabilities
= 100,258 – 40,356 = 59,902
2 Balance-sheet-based aggregate accruals = Net operating assets 2012 – Net operating assets 2011
= 59,902 – 44,446 = 15,456
3 Balance-sheet-based accruals ratio = 100 × Balance-sheet-based aggregate accruals ÷ Avg. net operating assets
= 100 × 15,456 ÷ [(59,902 + 44,446) ÷ 2] = 29.62%
| Ratio | Description | The company |
|---|---|---|
| Balance-sheet-based accruals ratio | Ratio is found by dividing balance-sheet-based aggregate accruals by average net operating assets. | Using the balance-sheet-based accruals ratio, Johnson & Johnson deteriorated earnings quality from 2011 to 2012. |
ADVERTISEMENT
Cash-Flow-Statement-Based Accruals Ratio
Johnson & Johnson, cash flow statement computation of aggregate accruals
USD $ in millions
| Dec 30, 2012 | Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | Dec 31, 2008 | ||
|---|---|---|---|---|---|---|
| Net earnings attributable to Johnson & Johnson | 10,853 | 9,672 | 13,334 | 12,266 | 12,949 | |
| Less: Net cash flows from operating activities | 15,396 | 14,298 | 16,385 | 16,571 | 14,972 | |
| Less: Net cash used by investing activities | (4,510) | (4,612) | (7,854) | (7,598) | (4,187) | |
| Cash-flow-statement-based aggregate accruals | (33) | (14) | 4,803 | 3,293 | 2,164 | |
| Cash-Flow-Statement-Based Accruals Ratio, Comparison to Industry | ||||||
| Johnson & Johnson1 | -0.06% | -0.03% | 10.51% | 7.55% | ||
| Industry, Health Care | 2.96% | 0.05% | 3.91% | 14.33% | ||
2012 Calculations
1 Cash-flow-statement-based accruals ratio = 100 × Cash-flow-statement-based aggregate accruals ÷ Avg. net operating assets
= 100 × -33 ÷ [(59,902 + 44,446) ÷ 2] = -0.06%
| Ratio | Description | The company |
|---|---|---|
| Cash-flow-statement-based accruals ratio | Ratio is found by dividing cash-flow-statement-based aggregate accruals by average net operating assets. | Using the cash-flow-statement-based accruals ratio, Johnson & Johnson deteriorated earnings quality from 2011 to 2012. |
ADVERTISEMENT





